FibroGen - 53 Year Dividend History | FGEN
Historical dividend payout and yield for FibroGen (FGEN) since 1971. The current TTM dividend payout for FibroGen (FGEN) as of November 21, 2024 is $0.00. The current dividend yield for FibroGen as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.040B |
$0.148B |
|
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
